<qa>  What is Montanide ISA-51?- Determine objective clinical response in patients with progressive, unresectable metastatic melanoma treated with recombinant LMB-2 immunotoxin and peptide vaccination comprising gp100:209-217 210M antigen, MART-1:27-35 antigen, and Montanide ISA-51. 